Showing Results for
- Academic Journals (14)
Search Results
- 14
Academic Journals
- 14
-
From:Archives of Pathology & Laboratory Medicine (Vol. 146, Issue 4) Peer-ReviewedContext.--Next-generation sequencing-based assays are increasingly used in clinical molecular laboratories to detect somatic variants in solid tumors and hematologic malignancies and to detect constitutional variants....
-
From:Archives of Pathology & Laboratory Medicine (Vol. 146, Issue 4) Peer-ReviewedContext.--Grading small foci of prostate cancer on a needle biopsy is often difficult, yet the clinical significance of accurate grading remains uncertain. Objective.--To assess if grading of limited adenocarcinoma on...
-
From:Archives of Pathology & Laboratory Medicine (Vol. 146, Issue 4) Peer-ReviewedContext.--From the onset of the human immunodeficiency virus (HIV) pandemic in the 1980s to the recent coronavirus disease 2019 (COVID-19) pandemic, multiple viral pandemics have occurred and all have been associated...
-
From:Archives of Pathology & Laboratory Medicine (Vol. 146, Issue 4) Peer-ReviewedContext.--Measurable (minimal) residual disease (MRD) is an independent prognostic factor for survival outcomes in patients with lymphoid and plasma cell malignancies and has been incorporated into consensus criteria...
-
From:Archives of Pathology & Laboratory Medicine (Vol. 146, Issue 4) Peer-ReviewedContext.--Multiple articles and surveys in the literature suggest that medical students find a career in pathology undesirable and believe it is disproportionately focused primarily on the autopsy. Objective.--To...
-
From:Archives of Pathology & Laboratory Medicine (Vol. 146, Issue 4) Peer-ReviewedTo the Editor.--On November 10, 2021, the US Food and Drug Administration (FDA) announced a class I recall, "Potential for false positive results with certain lots of Ellume coronavirus disease-19 (COVID-19) home tests...
-
From:Archives of Pathology & Laboratory Medicine (Vol. 146, Issue 4) Peer-ReviewedContext.--Hemophagocytic lymphohistiocytosis (HLH) is a rare, life-threatening disorder of immune regulation that can eventually result in end-organ damage and death. HLH is characterized by uncontrolled activation of...
-
From:Archives of Pathology & Laboratory Medicine (Vol. 146, Issue 4) Peer-ReviewedThe COVID-19 pandemic resulted in a significant expansion of infectious diseases testing technology. (1) As of November 2021, the US Food and Drug Administration (FDA) has conferred emergency use authorization (EUA) to...
-
From:Archives of Pathology & Laboratory Medicine (Vol. 146, Issue 4) Peer-ReviewedContext.--Program requirements for Selective Pathology fellowships in the United States were established by the Accreditation Council for Graduate Medical Education (ACGME) in 2011 to govern fellowships providing...
-
From:Archives of Pathology & Laboratory Medicine (Vol. 146, Issue 4) Peer-ReviewedContext.--The original guideline, "Validating Whole Slide Imaging for Diagnostic Purposes in Pathology," was published in 2013 and included 12 guideline statements. The College of American Pathologists convened an expert...
-
From:Archives of Pathology & Laboratory Medicine (Vol. 146, Issue 4) Peer-ReviewedContext.--In the early 1980s, a monoclonal antibody termed Ki-1 was developed against a cell line derived from a patient with Hodgkin lymphoma. This antibody detected a limited number of benign activated lymphocytes in...
-
From:Archives of Pathology & Laboratory Medicine (Vol. 146, Issue 4) Peer-ReviewedContext.--Recurrence score (RS) testing was developed and validated in invasive ductal and rare lobular carcinomas, although it is used for all special types of breast cancers. Objective.--To determine association of...
-
From:Archives of Pathology & Laboratory Medicine (Vol. 146, Issue 4) Peer-ReviewedContext.--The diagnosis of classic Hodgkin lymphoma (CHL) traditionally requires surgical tissue biopsy because of the paucity of diagnostic Hodgkin and Reed-Sternberg cells. Diagnosis can be challenging in small core...
-
From:Archives of Pathology & Laboratory Medicine (Vol. 146, Issue 4) Peer-ReviewedContext.--Plasmablastic morphology can be seen in several uncommon lymphoproliferative neoplasms. Sometimes it is difficult to distinguish these neoplasms from each other. Objective.--To review the current...